top of page
Cover-Blank.jpeg

Increased protease-activated receptor 1 autoantibodies are associated with severe COVID-19

Published date

December 27, 2022

Abstract


In patients with severe #COVID19, increased levels of autoantibodies against PAR1 were found. These might serve as allosteric agonists of PAR1 on endothelial cells and platelets, and thus might contribute to the pathogenesis of microthrombosis in COVID-19.

Contribute to the GPCR News

Coming soon

More from Dr. GPCR

Powered by


All Rights Reserved © 2020 - 2024

Dr. GPCR CORP is a 501(c)(3) non profit organization

  • Facebook
  • Twitter
  • LinkedIn
  • Instagram
bottom of page